Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Scandinavian Journal of Immunology|February 1, 1997
Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytesM J Maeurer, W Walter, D Martin, et al.The Laryngoscope|February 24, 1998
Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H miceJ N Myers, A Mank-Seymour, L Zitvogel, et al.Transplantation|December 16, 2000
Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individualsD Metes, W Storkus, A Zeevi, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1996
Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptorsJ Galon, J F Gauchat, N Mazières, et al.The Journal of Experimental Medicine|April 1, 1996
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial originM J Maeurer, D Martin, W Walter, et al.The Cancer Journal From Scientific American|February 24, 2000
Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunityM T Lotze, M Shurin, C Esche, et al.The Cancer Journal From Scientific American|February 11, 1998
The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapyM T Lotze, B Hellerstedt, L Stolinski, et al.Pageof 1